S&P Futures
4,049.75 -34.50 (-0.84%) Dow Futures
33,849.00 -197.00 (-0.58%) Nasdaq Futures
12,079.25 -143.00 (-1.17%) Russell 2000 Futures
1,902.10 -17.40 (-0.91%) Crude Oil
79.52 -0.16 (-0.20%) Gold
1,941.90 -3.70 (-0.19%)
Stoke Therapeutics, Inc. (STOK)
After hours:
Chart Events
Performance Outlook
| Previous Close | 9.41 |
| Open | 9.46 |
| Bid | 9.50 x 2200 |
| Ask | 10.23 x 1000 |
| Day's Range | 9.46 - 9.74 |
| 52 Week Range | 6.88 - 26.60 |
| Volume | |
| Avg. Volume | 339,283 |
| Market Cap | 354.297M |
| Beta (5Y Monthly) | 0.63 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.09 |
| Earnings Date | Mar 08, 2023 - Mar 13, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 49.18 |
- Simply Wall St.
Companies Like Stoke Therapeutics (NASDAQ:STOK) Can Afford To Invest In Growth
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
- Business Wire
Stoke Therapeutics Highlights Strategic Priorities and Anticipated Milestones for 2023
BEDFORD, Mass., January 09, 2023--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today outlined its expected milestones and the following strategic priorities for 2023:
- Business Wire
Stoke Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
BEDFORD, Mass., January 04, 2023--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today announced that management will present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, at 2:15 p.m. ET (11:15 a.m. PT).
